Effects of Vitamin B3 in Patients With Ataxia Telangiectasia

Clinical trial NCT03962114 · COMPLETED

Trial details

NCT number: NCT03962114
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ataxia Telangiectasia ATM Gene Mutation

Start date: 2019-03-18
Primary completion: 2019-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.